Hana Golan

専門分野: Hematologist
24年の経験
話します:
English, Hebrew
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
Serves as Director of Pediatric Hemato-Oncology & BMT and Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Dr. Hana Golan

MD | Pediatric Hematology-Oncology & Bone Marrow Transplant Specialist

Department:

Pediatric Hemato-Oncology & BMT Division, Sheba Medical Center

Languages:

Hebrew, English

Professional Summary

Dr. Hana Golan is a leading pediatric hemato-oncologist and Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant (BMT) Division at Sheba Medical Center. She specializes in the treatment of childhood cancers and complex hematological disorders, with a particular focus on neuroblastoma and high-risk solid tumors.

With decades of clinical and research experience, Dr. Golan combines advanced oncology protocols with personalized treatment strategies aimed at improving outcomes in challenging pediatric cases.

Areas of Expertise

Pediatric oncology (solid tumors and hematologic malignancies)

Neuroblastoma (including high-risk cases)

Bone marrow and stem cell transplantation

Leukemia and lymphoma in children

Chronic and inherited blood disorders

Immune deficiencies and metabolic disorders

Personalized chemotherapy and targeted therapy protocols

Education & Training

MD, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology

Residency in Pediatrics, Sheba Medical Center

Residency in Pediatric Hematology-Oncology, Sheba Medical Center

Advanced research training in transplantation immunology, Weizmann Institute of Science

Additional training in clinical research, biomedical informatics, and healthcare management

Clinical & Research Experience

Dr. Golan leads one of the most advanced pediatric oncology programs in the region, managing complex and high-risk cases. She is actively involved in the development and implementation of international treatment protocols, particularly in neuroblastoma.

Her research focuses on:

cancer stem cells in pediatric tumors

development of targeted therapies

novel approaches to treatment-resistant malignancies

emerging therapeutic strategies, including cannabinoid-related research in oncology

Clinical Trials & International Collaboration

Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol

Investigator in international Phase I/II clinical trials targeting advanced pediatric cancers

National coordinator of multicenter oncology protocols

Academic & Teaching Roles

Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University

Lecturer in pediatric hematology-oncology for physicians and nurses